Went to college at Harvard to study molecular biology and graduate training at UC Berkeley in biochemistry.
Partner and investor to companies such as GenEdit, Culture Biosciences, Serotiny, Unnatural Products, Aether, Coral Genomics, and EnClear Therapies. Founder of Axial, an investment business in early-stage companies led by great inventors and building unique business models in life sciences.